Previous 10 | Next 10 |
For Q4, cbdMD (YCBD) +3.2% AH, estimated prelim results wherein net sales are expected to range between $1.6 and $1.65M (+30-34% Q/Q)."We are seeing an incredible growth trajectory in our Paw CBD brand. We now project total net sales of the Paw CBD brand to reach approximately $6 mi...
According To Data Provided By Market Analytics Firm Nielsen Global Connect, cbdMD Expects Paw CBD To Command A 10% to 15% Market Share In The US Pet CBD Market In Calendar 2020 cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading and...
Led by brands' strong retail sales performance and sell through, cbdMD (YCBD) +3% PM, announced that Life Time, the nation's premier healthy lifestyle brand, will be expanding the cbdMD product sales into all its Life Time Cafes nationwide as of Nov.1, 2020.With 150+ destinations in 41 m...
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced today that Life Time, the nation's premier healthy lifestyle brand, will be expanding their cbdMD product sales into all its Life Time Cafes nationwide as of November 1, 2020, due to the brands’ strong retail sales performanc...
While much of the cannabis industry is mired in a downturn, the CBD market looks like a bright spot. Here is one company focused on CBD that has been flying under the radar and worth a look: cbdMD (YCBD). The cannabis sector has struggled mightily over the past year, with the ETFMG Alt...
cbdMD, Inc. (NYSE: YCBD) reported preliminary financial results for the fourth quarter of fiscal 2020, and the year ended September 30, 2020. The company said that net sales revenue for fiscal 2020 is expected to range between $41.7 and $41.8 compared to $23.7 million in fisca...
CbdMD (YCBD) reports preliminary financial results for Q4 and FY 2020 ended September 30.Q4 net sales revenue is anticipated in the range of $11.5M and $11.7M vs. $9.54M in Q4 2019. The average analyst expectation is $11.03M.FY20 net sales revenue is expected between $41.7M and $41.8M ($41.22...
Year Over Year Net Sales Expected to Increase Between 76% and 77% Year Over Year Quarterly Net Sales Expected to Increase Between 21% and 23% Company Reaffirms Commitment To Reaching Positive Adjusted Operating Income In Calendar 2020 cbdMD, Inc. (NYSE Am...
Gainers: Sanchez Midstream Partners (SNMP) +124%.VivoPower International (VVPR) +92%.SpartanNash (SPTN) +34%.Precigen (PGEN) +29%.India Globalization Capital (IGC) +26%.Marine Petroleum Trust (MARPS) +25%.Just Energy (JE) +23%.cbdMD (YCBD) +22%.Medigus (MDGS) +21%.AcelRx Pharma...
Gainers: Precigen (PGEN) +26%. Medigus (MDGS) +24%. Aclaris Therapeutics (ACRS) +17%. cbdMD (YCBD) +15%. Abeona Therapeutics (ABEO) +12%.Losers: Mallinckrodt (MNK) -18%. GeoVax Labs (GOVX) -13%. AgeX Therapeutics (AGE) -12%. COMPASS Pathways (CMPS) -9%. ThermoGen...
News, Short Squeeze, Breakout and More Instantly...
Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) - cbdMD , Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's human clinical trial data...
Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mush...